Ownership as of September 30, 2021. Ten largest shareholders.
| Name | Series A shares | Series B shares | Share capital % | Voting rights % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENTS AB | 377 736 | 510 478 | 7.91 | 29.32 |
| SIX SIS AG, W8IMY | 0 | 1 186 087 | 10.57 | 8.11 |
| FJÄRDE AP-FONDEN | 0 | 1 120 000 | 9.98 | 7.66 |
| SWEDBANK ROBUR NY TEKNIK BTI | 0 | 579 172 | 5.16 | 3.96 |
| AMF AKTIEFOND SMÅBOLAG | 0 | 501 585 | 4.47 | 3.43 |
| TREDJE AP-FONDEN | 0 | 501 579 | 4.47 | 3.43 |
| UNIONEN | 0 | 322 196 | 2.87 | 2.20 |
| CBNY-NORGES BANK | 0 | 321 989 | 2.87 | 2.20 |
| DANGOOR, DAVID | 0 | 306 421 | 2.73 | 2.10 |
| ÅLANDSBANKEN I ÄGARES STÄLLE | 0 | 261 759 | 2.33 | 1.79 |
| Sub-total | 377736 | 5 611 266 | 53.36 | 64.20 |
| Other shareholders | 0 | 5 237 182 | 46.64 | 35.80 |
| Total | 377736 | 10848448 | 100.00 | 100.00 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.